pdf (Español (España))
FLIP
Authors
Abstract
Introduction: Diabetes mellitus is a challenge for health systems due to the complexity of care, and the quality and access to treatment. Objective: To describe the clinical characteristics of patients in the Diabetes Mellitus State Register in the state of Hidalgo in Mexico from 2007 to 2012. Methods: Cross-sectional descriptive study of the Diabetes State Register (DSR) between 2007 and 2012. Simple statistics description to characterize the studied population, proportions and reasons for qualitative variables and for quantitative measures of central tendency and continuous and dispersion variables (media, median, mode, deviation, standard and variance) were carried out. The t student test was used for the analysis of continuous variables. Results: 10,198 patients from the Diabetes State Register were identified; 66.4% were women and 33.52% men. The mean age was 52.2±12.8. Regarding fasting glucose, the mean was 239.1±95.3 mg/dl; the post-prandial glucose mean was 293.6±122.7 mg/dl and casual glucose was 247.9±102.3 mg/ dl. The DSR activities included 5,795 people that were detected at that time which correspond to 56.8% from which 11.9% reported having blurred vision, polyuria 48.5%, infections 4.7%, polydipsia 44.07%, polyphagia 13.19%, weight loss 26.9% and fatigue 35.2%. When comparing people under treatment with those admitted, no statistical difference was found While those who were under treatment, who mentioned only having diet were 33.5%, metformin72.58%, sulfonylureas 62.9%, acarbose 3.59%, insulin 9.4%, and rosiglitazone 0.66%. Discussion: The Diabetes State Register has low glycemic control standards. Development of internal indicators is suggested to allow medical staff to make decisions from inside the unit and provide a better quality of care, compliance and opportunity.
Keywords:
References
2. International Diabetes Federation. Diabetes atlas. 3rd edition. Bélgica: International Diabetes Federation; 2008.
3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Care 1997; 20:1183-1197.
4. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus2, the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160-3167.
5. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición 2012, Instituto Nacional de Salud Pública. México [sitio en internet]. [Consultado agosto 28 de 2013]. Disponible en: http://ensanut.insp.mx/doctos/analiticos/DiabetesMellitus.pdf
6. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición 2012, Resultados por entidad federativa: Hidalgo. Instituto Nacional de Salud Pública. México [sitio en internet]. [Consultado abril 14 de 2015]. Disponible en: http://ensanut.insp.mx/informes/Hidalgo-OCT.pdf.
7. Secretaría de Salud. Manual de Procedimientos Estandarizados para la Vigilancia Epidemiológica de la Diabetes Mellitus Tipo 2. Dirección General de Epidemiología. México. 2012.
8. Rodríguez-Saldaña J, Jonguitud-Falcón A, Clark CL, Escorza-Domínguez AB, Morales de Teresa M, Ortiz-Gress AA. Optimizar la atención sanitaria en México con recursos limitados. Diabetes Voice 2003; 48(3):20-22.
9. Frenk J, González-Pier E, Gómez-Dantés O, Lezana MA, Knaul FM. Reforma integral para mejorar el desempeño del sistema de salud en México. Salud Pública Mex 2007; 49(1):S23-S36.
10. González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M, Porras-Condey R, Carvalho N, et al. Definición de prioridades para las intervenciones de salud en el Sistema de Protección Social en Salud de México. Salud Pública Mex 2007; 49(1):S37-S52
11. Diario Oficial de la Nación. NORMA Oficial Mexicana NOM-015-SSA2-2010, Para la prevención, tratamiento y control de la diabetes mellitus. [sitio en internet]. [Consultado abril 15 de 2015]. Disponible en: http://dof.gob.mx/nota_detalle.php?codigo=5168074&fecha=23/11/2010
12. Tratamiento de la Diabetes Mellitus tipo 2 en el primer nivel de Atención. México: Instituto Mexicano del Seguro Social. [sitio en internet]. [Consultado abril 15 de 2015]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/718_GPC_Tratamiento_de_diabetes_mellitus_tipo_2_/718GER.pdf
13. Secretaría de Salud. REGLAMENTO de la Ley General de Salud en Materia de Investigación para la Salud. [sitio en internet]. [Consultado julio 28 de 2013]. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/compi/rlgsmis.html
14. Epping-Jordan J, Galea G, Tukuitonga C, Beaglehole R. Preventing chronic diseases: taking stepwise action. Lancet 2005; 366:1667-1671.
15. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 2004; 291(3):335-342
16. Villegas-Perrasse A, Abad-Sol B, Faciolince S, Hernández N, Maya C, Parra Lucrecia, et al. El control de la diabetes mellitus y sus complicaciones en Medellín, Colombia, 2001-2003. Rev Panam Salud 2006; 20(6):393-402.
17. Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernández-Ávila M, et al. Las enfermedades crónicas no transmisibles en México: sinopsis. epidemiológica y prevención integral. Salud Pública Mex 2008; 50:419-427.
18. Reid KS, Martin BD, Duerksen F, Nicolle LE, Garrett M, Simonsen JN, et al. Diabetic foot complications in a northern Canadian aboriginal community, Foot Ankle Int 2006; 27(12):1065-1073.
19. Kramer H. Screening for kidney disease in adults with diabetes and prediabetes. Curr Opin Nephrol Hypertens 2005; 14(3):249-255.
20. Górriz Teruel JL, Otero González A. Social and health impact of advanced chronic kidney disease. Nefrologia 2008; 28(3):7-15.
21. Laliberté F, Bookhart BK, Vekeman F, Corral M, Duh MS, Bailey RA, et al. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm 2009; 15(4):312-322.
22. Barquera S, Campos-Nonato I, Aguilar-Salinas C, López-Ridaura R, Arredondo A, Rivera-Dommarco J. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. Global Health 2013; 9:3.
Downloads
